208 related articles for article (PubMed ID: 12759432)
1. Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3' Igh enhancer, hs3.
Gordon SJ; Saleque S; Birshtein BK
J Immunol; 2003 Jun; 170(11):5549-57. PubMed ID: 12759432
[TBL] [Abstract][Full Text] [Related]
2. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
Sepulveda MA; Emelyanov AV; Birshtein BK
J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.
Tang H; Sharp PA
Immunity; 1999 Nov; 11(5):517-26. PubMed ID: 10591177
[TBL] [Abstract][Full Text] [Related]
4. Identification of a candidate regulatory element within the 5' flanking region of the mouse Igh locus defined by pro-B cell-specific hypersensitivity associated with binding of PU.1, Pax5, and E2A.
Pawlitzky I; Angeles CV; Siegel AM; Stanton ML; Riblet R; Brodeur PH
J Immunol; 2006 Jun; 176(11):6839-51. PubMed ID: 16709844
[TBL] [Abstract][Full Text] [Related]
5. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
Hu HM; Kanda K; Zhang L; Boxer LM
Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
[TBL] [Abstract][Full Text] [Related]
6. The 3' IgH regulatory region: a complex structure in a search for a function.
Khamlichi AA; Pinaud E; Decourt C; Chauveau C; Cogné M
Adv Immunol; 2000; 75():317-45. PubMed ID: 10879288
[No Abstract] [Full Text] [Related]
7. Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins.
Michaelson JS; Singh M; Snapper CM; Sha WC; Baltimore D; Birshtein BK
J Immunol; 1996 Apr; 156(8):2828-39. PubMed ID: 8609402
[TBL] [Abstract][Full Text] [Related]
8. Regulation of epsilon germline transcription and switch region mutations by IgH locus 3' enhancers in transgenic mice.
Laurencikiene J; Tamosiunas V; Severinson E
Blood; 2007 Jan; 109(1):159-67. PubMed ID: 16968901
[TBL] [Abstract][Full Text] [Related]
9. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines.
Schweitzer BL; DeKoter RP
J Immunol; 2004 Jan; 172(1):144-54. PubMed ID: 14688320
[TBL] [Abstract][Full Text] [Related]
10. NFE, a new transcriptional activator that facilitates p50 and c-Rel-dependent IgH 3' enhancer activity.
Linderson Y; Cross D; Neurath MF; Pettersson S
Eur J Immunol; 1997 Feb; 27(2):468-75. PubMed ID: 9045919
[TBL] [Abstract][Full Text] [Related]
11. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
Laurencikiene J; Deveikaite V; Severinson E
J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
[TBL] [Abstract][Full Text] [Related]
12. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
[TBL] [Abstract][Full Text] [Related]
13. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
O'Riordan M; Grosschedl R
Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
[TBL] [Abstract][Full Text] [Related]
14. Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells.
Schweitzer BL; Huang KJ; Kamath MB; Emelyanov AV; Birshtein BK; DeKoter RP
J Immunol; 2006 Aug; 177(4):2195-207. PubMed ID: 16887979
[TBL] [Abstract][Full Text] [Related]
15. Yin Yang 1 is a critical regulator of B-cell development.
Liu H; Schmidt-Supprian M; Shi Y; Hobeika E; Barteneva N; Jumaa H; Pelanda R; Reth M; Skok J; Rajewsky K; Shi Y
Genes Dev; 2007 May; 21(10):1179-89. PubMed ID: 17504937
[TBL] [Abstract][Full Text] [Related]
16. LR1, a lipopolysaccharide-responsive factor with binding sites in the immunoglobulin switch regions and heavy-chain enhancer.
Williams M; Maizels N
Genes Dev; 1991 Dec; 5(12A):2353-61. PubMed ID: 1748289
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.
Osborne A; Zhang H; Yang WM; Seto E; Blanck G
Mol Cell Biol; 2001 Oct; 21(19):6495-506. PubMed ID: 11533238
[TBL] [Abstract][Full Text] [Related]
18. B cell development arrest upon insertion of a neo gene between JH and Emu: promoter competition results in transcriptional silencing of germline JH and complete VDJ rearrangements.
Delpy L; Decourt C; Le Bert M; Cogné M
J Immunol; 2002 Dec; 169(12):6875-82. PubMed ID: 12471120
[TBL] [Abstract][Full Text] [Related]
19. YY1 activates Msx2 gene independent of bone morphogenetic protein signaling.
Tan DP; Nonaka K; Nuckolls GH; Liu YH; Maxson RE; Slavkin HC; Shum L
Nucleic Acids Res; 2002 Mar; 30(5):1213-23. PubMed ID: 11861914
[TBL] [Abstract][Full Text] [Related]
20. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
Hodawadekar S; Park K; Farrar MA; Atchison ML
J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
